Alnylam Pharmaceuticals
ALNY
#598
Rank
$34.12 B
Marketcap
$264.60
Share price
-1.62%
Change (1 day)
60.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company